We are thrilled to announce the launch of our brand-new mobile application. Now you can enjoy the latest science news, in-depth articles, and engaging multimedia content on all your mobile devices, ...

The Uttar Pradesh Public Service Commission (UPPSC) has officially activated the link for the UPPSC LT Grade Result 2026. As of February 18, 2026, the preliminary merit lists for key subjects, ...

A Dalai Lama once said that our prime purpose in this life is to help others – and he may have been right. Scientists have found that having a positive impact on other people seems to be a key element ...

Battlefield Studios has deployed a new update for Battlefield 6 today, and this one is billed as a small patch that offers some quality-of-life improvements for the military shooter. Chief among the ...

Genetics may explain about half of a person's lifespan, a study has suggested, pointing to a far more significant role of genetics than earlier research indicated. The findings, published in the ...

New study into ‘heritability’ shows that 50% of the variation in human lifespan could be down to genetics Some people who live to a great age put it down to an evening tot of whisky, others to staying ...

Chiba, Japan, January 12, 2026—A team at Japan’s National Institutes for Quantum Science and Technology (QST) has published a field-defining Perspective that places the societal payoff of quantum ...

Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved aggressively to shore up pipelines and offset looming revenue losses, according to ...

El Monte-based technology company Fulgent Genetics Inc. agreed to acquire selected assets of Bako Diagnostics, a pathology laboratory based in Alpharetta, GA, and to acquire StrataDx, a ...

GATE Life Sciences Question Paper PDF: Every aspirant who is going to sit in the Graduate Aptitude Test in Engineering (GATE) Life Sciences (XL) exam 2026 must practice the GATE Life Sciences previous ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The developer behind ...

Earlier in December 2025, SELLAS Life Sciences Group reported Phase 2 data showing its investigational drug SLS009, combined with azacitidine and venetoclax, achieved a 46% overall response rate in ...